Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oscar HealthMEX:OSCR +4.17%59 EV-to-EBITDA is 7.66 as of Aug. 09, 2026, which is 935% above its 10-year median of 0.74. GuruFocus rates MEX:OSCR with a GF Score™ of 59/100 and a GF Value™ of MXN400.37 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 15 Healthcare Plans companies, Oscar Health ranks better than 73.33% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Oscar Health's enterprise value is MXN85,530 Mil.
Oscar Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was MXN11,172 Mil. Therefore, Oscar Health's EV-to-EBITDA for today is 7.66.
The historical rank and industry rank for Oscar Health's EV-to-EBITDA or its related term are showing as below:
MEX:OSCR'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -27.45 Med: 0.74 Max: 697.43
Current: 7.84
During the past 7 years, the highest EV-to-EBITDA of Oscar Health was 697.43. The lowest was -27.45. And the median was 0.74.
MEX:OSCR's EV-to-EBITDA is ranked better than 73.33% of 15
companies
in the Healthcare Plans industry
Industry Median: 13.79
vs MEX:OSCR: 7.84
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Oscar Health's PE Ratio (TTM) for today is calculated as:
Oscar Health's share price for today is MXN474.52.
Oscar Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN23.699.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Oscar Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:OSCR vs MOH, ALHC, PGNY: EV-to-EBITDA Comparison
For the Healthcare Plans subindustry, Oscar Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oscar Health EV-to-EBITDA vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Oscar Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Oscar Health's EV-to-EBITDA falls into.
Oscar Health's current Enterprise Value is MXN85,530 Mil.
Oscar Health's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN11,172 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oscar Health (MEX:OSCR) has a EV-to-EBITDA of 7.66 as of Aug. 09, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Oscar Health. This is 935% above median its historical median of 0.74. According to the industry distribution chart, Oscar Health ranks #4 out of 15 companies in the Healthcare Plans industry, placing it in the top 26.7%.
Is Oscar Health's EV-to-EBITDA too high?
Oscar Health's current EV-to-EBITDA of 7.66 is 935% above median its 10-year median of 0.74. The Healthcare Plans industry median EV-to-EBITDA is 13.79. Oscar Health's value of 7.66 is 44.5% below this industry median. Based on the distribution chart, Oscar Health ranks #4 out of 15 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Oscar Health has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Oscar Health's EV-to-EBITDA compare to MOH and ALHC?
According to the Healthcare Plans industry distribution chart, Oscar Health ranks #4 out of 15 companies for EV-to-EBITDA. This puts Oscar Health in the upper half of its industry. The industry median EV-to-EBITDA is 13.79. Oscar Health's value of 7.66 is 44.5% below this benchmark. While the company's 10-year median is 0.74 vs. the industry median of 13.79, Oscar Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Plans company?
The median EV-to-EBITDA among Healthcare Plans companies is 13.79, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oscar Health's current EV-to-EBITDA of 7.66 is 44.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Oscar Health. For the Healthcare Plans industry, the median EV-to-EBITDA is 13.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oscar Health's current EV-to-EBITDA is 7.66, which is 935% above median its own 10-year median of 0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oscar Health stock overvalued right now?
Based on GuruFocus' analysis, Oscar Health (MEX:OSCR) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN400.37, compared to a current price of MXN474.52 — trading 18.5% above its estimated fair value. The current EV-to-EBITDA is 7.66, which is 935% above median its 10-year median of 0.74 and 44.5% below the Healthcare Plans industry median of 13.79. Oscar Health's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Oscar Health (MEX:OSCR), the current EV-to-EBITDA is 7.66 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oscar Health (MEX:OSCR) Overvalued in 2026?
Based on GuruFocus' analysis, Oscar Health stock appears to be overvalued.
The current stock price of MXN474.52 is trading 18.5% above its estimated GF Value™ of MXN400.37.
GuruFocus considers Oscar Health to be Modestly Overvalued.
Key valuation signals for MEX:OSCR:
EV-to-EBITDA: 7.66 (935% above median its 10-year median of 0.74)
GF Value™: MXN400.37 vs. price of MXN474.52 (18.5% above fair value)
Industry Position: 44.5% below the Healthcare Plans median (#4 of 15)
No single metric tells the full story. See the MEX:OSCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
59GF Score
Get the complete analysis for MEX:OSCR
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:OSCR has been successfully added to your 
